KRISTEN MALONE: Open Payments
NPI 1669803797 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 13 payments from 10 companies in 2025. Trend: 2023 $328 · 2024 $523 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Optinose US, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Organon LLC | 1 | $22 |
| Cycle Pharmaceuticals Inc | 1 | $20 |
Products named: DUPIXENT, INSPIRE, NEFFY, NUCALA, Xhance, BREZTRI, CUVITRU, FASENRA.
Industry payments across TX — which companies pay providers there.
